Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial

Detalles Bibliográficos
Autores principales: Clement, Clare, Rapport, Frances
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660126/
http://dx.doi.org/10.1186/1745-6215-16-S2-P72
_version_ 1782402737821974528
author Clement, Clare
Rapport, Frances
author_facet Clement, Clare
Rapport, Frances
author_sort Clement, Clare
collection PubMed
description
format Online
Article
Text
id pubmed-4660126
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46601262015-12-02 Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial Clement, Clare Rapport, Frances Trials Poster Presentation BioMed Central 2015-11-16 /pmc/articles/PMC4660126/ http://dx.doi.org/10.1186/1745-6215-16-S2-P72 Text en Copyright © 2015 Clement and Rapport http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Clement, Clare
Rapport, Frances
Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title_full Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title_fullStr Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title_full_unstemmed Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title_short Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
title_sort patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660126/
http://dx.doi.org/10.1186/1745-6215-16-S2-P72
work_keys_str_mv AT clementclare patientandhealthprofessionalsperspectivesontheuseofciclosporinandinfliximabwhentreatingacutesevereulcerativecolitisanaddeddimensiontotheconstructtrial
AT rapportfrances patientandhealthprofessionalsperspectivesontheuseofciclosporinandinfliximabwhentreatingacutesevereulcerativecolitisanaddeddimensiontotheconstructtrial

Ejemplares similares